AU550892B2 - 3-benzazepine and beta blocking agent composition - Google Patents

3-benzazepine and beta blocking agent composition

Info

Publication number
AU550892B2
AU550892B2 AU90844/82A AU9084482A AU550892B2 AU 550892 B2 AU550892 B2 AU 550892B2 AU 90844/82 A AU90844/82 A AU 90844/82A AU 9084482 A AU9084482 A AU 9084482A AU 550892 B2 AU550892 B2 AU 550892B2
Authority
AU
Australia
Prior art keywords
compound
composition
dopaminergic
renal
benzazepine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU90844/82A
Other languages
English (en)
Other versions
AU9084482A (en
Inventor
Dennis Marvin Ackerman
Varry Alan Berkowitz
Virgil Daniel Wiebelhaus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of AU9084482A publication Critical patent/AU9084482A/en
Application granted granted Critical
Publication of AU550892B2 publication Critical patent/AU550892B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
AU90844/82A 1981-12-08 1982-11-24 3-benzazepine and beta blocking agent composition Ceased AU550892B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP81110252A EP0081006B1 (en) 1981-12-08 1981-12-08 Pharmaceutical compositions comprising 7,8-dihydroxy-1(hydroxyphenyl)-2,3,4,5-tetrahydro-1h-3-benzazepine derivatives and a beta-adrenergic blocking compound
EP81110252 1981-12-08

Publications (2)

Publication Number Publication Date
AU9084482A AU9084482A (en) 1983-06-16
AU550892B2 true AU550892B2 (en) 1986-04-10

Family

ID=8188060

Family Applications (1)

Application Number Title Priority Date Filing Date
AU90844/82A Ceased AU550892B2 (en) 1981-12-08 1982-11-24 3-benzazepine and beta blocking agent composition

Country Status (18)

Country Link
US (1) US4469690A (enExample)
EP (1) EP0081006B1 (enExample)
JP (1) JPS58105921A (enExample)
AT (1) ATE15762T1 (enExample)
AU (1) AU550892B2 (enExample)
CA (1) CA1183777A (enExample)
DE (1) DE3172458D1 (enExample)
GR (1) GR77842B (enExample)
HK (1) HK11489A (enExample)
HU (1) HU187804B (enExample)
IL (1) IL67310A (enExample)
MY (1) MY8700934A (enExample)
NZ (1) NZ202510A (enExample)
PH (1) PH22073A (enExample)
PT (1) PT75915B (enExample)
SG (1) SG61188G (enExample)
ZA (1) ZA829004B (enExample)
ZW (1) ZW25482A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0365134A1 (en) * 1988-09-16 1990-04-25 Smithkline Beecham Corporation Synergistic compositions of renal dopaminergic agent and angiotensin converting enzyme inhibitors
FI915717A7 (fi) * 1990-04-06 1991-12-04 Eisai Co Ltd Katekoliyhdistettä sisältävä kiinteä oraalinen valmiste
US6372712B1 (en) 1998-05-22 2002-04-16 The Board Of Trustees Of The Leland Stanford Jr. University Synthetic bifunctional molecules containing a drug moiety and presenter protein ligand
CA2450073C (en) 2001-07-25 2017-08-29 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
US7022342B2 (en) 2002-03-28 2006-04-04 Andrx Corporation, Inc. Controlled release oral dosage form of beta-adrenergic blocking agents
EP2671508B1 (en) 2005-04-28 2020-09-16 Proteus Digital Health, Inc. Pharma-informatics system
JP2010503710A (ja) 2006-09-18 2010-02-04 ラプトール ファーマシューティカル インコーポレイテッド 受容体関連タンパク質（ｒａｐ）結合体の投与による肝障害の処置
ES2919563T3 (es) 2009-02-20 2022-07-27 Enhanx Biopharm Inc Sistema de administración de medicamentos a base de glutatión
KR20180114970A (ko) 2009-05-06 2018-10-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4011319A (en) * 1975-07-02 1977-03-08 Smithkline Corporation Pharmaceutical compositions and methods involving benzazepine derivatives
DE2638716A1 (de) * 1976-08-27 1978-03-02 Ici Gmbh Antihypertensiva
US4160765A (en) * 1976-11-17 1979-07-10 Smithkline Corporation Method for 6-bromination of 1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine compounds
US4171359A (en) * 1978-04-12 1979-10-16 Smithkline Corporation Benz-tetrasubstituted 1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
US4265889A (en) * 1978-05-05 1981-05-05 Smithkline Corporation 6-Lower alkyl-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
US4192297A (en) * 1978-05-25 1980-03-11 Leopold Labrecque Therapeutic feet bathing device
DE2850078A1 (de) * 1978-11-18 1980-05-29 Basf Ag Aminopropanolderivate des 6-hydroxy-2,3,4,5-tetrahydro-1h-1- benzazepin-2-ons
EP0022330B1 (en) * 1979-07-10 1983-12-21 Smithkline Beckman Corporation Synergistic antihypertensive compositions

Also Published As

Publication number Publication date
MY8700934A (en) 1987-12-31
SG61188G (en) 1989-07-07
ZW25482A1 (en) 1983-02-23
IL67310A (en) 1988-09-30
EP0081006A1 (en) 1983-06-15
ZA829004B (en) 1983-09-28
ATE15762T1 (de) 1985-10-15
US4469690A (en) 1984-09-04
PH22073A (en) 1988-05-20
AU9084482A (en) 1983-06-16
CA1183777A (en) 1985-03-12
HU187804B (en) 1986-02-28
GR77842B (enExample) 1984-09-25
NZ202510A (en) 1985-09-13
PT75915A (en) 1982-12-01
JPS58105921A (ja) 1983-06-24
EP0081006B1 (en) 1985-09-25
HK11489A (en) 1989-02-17
DE3172458D1 (en) 1985-10-31
PT75915B (en) 1985-11-15

Similar Documents

Publication Publication Date Title
AU531057B2 (en) 6beta,7beta,15,16-dimethylene-1,4-androstadien-3-ones
AU565316B2 (en) Triphenylmethyl derivatives of glycero-3-phosphocholine and glycero-3-phosphoethanolamine
IT8467225A1 (it) Composti di solfonio, procedimento di preparazione di detti composti e composizioni farmacologiche contenenti i composti stessi.
SE8506078L (sv) Sett for stromlos forkoppring och komposition for utforande av settet
AU587995B2 (en) 1-substituted tetralin derivatives, their preparation and their use
AU9084482A (en) 3-benzazepine and beta blocking agent composition
ES513877A0 (es) "procedimiento de fabricacion de copolimeros de etileno y de x-olefinas con al menos 4 atomos de carbono".
BE884287A (fr) Composition absorbant l'eau, catheter, suture ou plaque de verre enduits de cette composition
OA07525A (fr) Dérivés d'acides-animés, leur préparation et utilisation ainsi que les compositions contenant ces dérivés.
ES510730A0 (es) "procedimiento para la preparacion de (2,2')-disulfuros de ditiazolilo".
ES515227A0 (es) "procedimiento para la preparacion de composiciones poliolefinicas autoextinguentes".
PT86665A (pt) Process for the preparation of 14,15-substituted lanosterols and of hypocholesterolemic compositions containing the same
GR852224B (enExample)
IT8421523A0 (it) Procedimento per la preparazione di 4'-epidoxorubicina.
Seo Recommendations for the Improvement of the Medical Licensing Examination
ES512427A0 (es) "procedimiento para la preparacion de eteres difenilicos dotados de propiedades herbicidas".
ES512940A0 (es) "procedimiento para la preparacion de colorantes azo-estilbenicos".
AU8298582A (en) 1-bis(ar.ylalkyl)-alkylimidazoles and spermicidal compositions
IT8223168A0 (it) Chinazoline piperidinil-sostituite aventi proprieta' farmacologiche, particolarmente proprieta'ipotensive, e procedimento per laloro preparazione.
AU8931082A (en) Xipamide and triamterene composition
FI813201A7 (fi) Menetelmä 4-okso-3,4-dihydro-2H-1,2- bentsotiatsiini-1,1,- dioksidi-3-karboksiamidi-johdannaisten valmistamvalmistamiseksi.
IT8433319V0 (it) Spiralex maxima securitas 2000 n. 5cu 285,70 mg
ES512943A0 (es) "procedimiento para la preparacion de 3-metil-3(0-metoxifenoxi)-benzo-2,4-dioxaciclohexanona".
IT1184687B (it) Derivato del piridone dotato di procprieta' cardiotoniche e composizioni farmaceutiche contenenti detto derivato